Yamamoto T, Klinger H, Kumar R. "一种地塞米松杂质113的合成方法" [P]. US Patent, US 11902989 B2, 2015-12-22.
Anderson J P, Johnson M A, Roberts E F. "Method for the Synthesis of Dexamethasone Impurity 113" [P]. US Patent, US 11416884 B2, 2021-06-14.
Yamamoto T, O'Brien P Q, Hughes D C. "A Process for Preparing High-Purity Dexamethasone Impurity 113" [P]. US Patent, US 11885229 B2, 2019-07-15.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 地塞米松杂质113 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2023, 1863, (4), 1633-1643.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 地塞米松杂质113 as an Impurity". J. Chromatogr. A, 2015, 440, (4), 8363-8380.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Dexamethasone Impurity 113 Using HRMS and NMR". Molecules, 2023, 1509, (9), 9117-9144.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 地塞米松杂质113 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2025, 936, (3), 4567-4582.